85650 Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

Office of the Secretary (OS), Department 

of Health and Human Services, is 

announcing it has submitted to the 

Office of Management and Budget 

(OMB) for review and clearance the 

following collection of information. The 

addresses section has been corrected to 

reflect the correct comments email 

address. 

DATES: Comments on the ICR must be 

received on or before January 28, 2021. 

ADDRESSES: Submit your comments to 

http://www.reginfo.gov/public/do/ 

PRAMain or via facsimile to (202) 395– 

5806. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990-New and project title for reference. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, OS/ 

DHHS has submitted the following 

proposed collection of information to 

OMB for review and clearance. 

OMB No. 0990-New—HHS Teletracking 

COVID–19 Portal; OMB Control 

Number 

Abstract: The data collected through 

this ICR informs the Federal 

Government’s understanding of disease 

patterns and furthers the development 

of policies for prevention and control of 

disease spread and impact related to the 

2019 Novel Coronavirus (COVID–19). 

One of the most important uses of the 

data collected through this ICR is to 

determine critical allocations of limited 

supplies (e.g., protective equipment and 

medication). For instance, this 

collection has been used to distribute 

Remdesivir, a vital therapeutic that HHS 

distributes to the American healthcare 

system, via distinct data calls on regular 

intervals. As of July 10, HHS reduced 

the number requests for data from 

hospitals to support allocations of 

Remdesivir. HHS has stopped sending 

out one-time requests for data to aid in 

the distribution of Remdesivir or any 

other treatments or supplies. This 

consolidated daily reporting is the only 

mechanism used for the distribution 

calculations, and daily reports are 

needed to ensure accurate calculations. 

Type of Respondent: We acknowledge 

the burden placed on many hospitals, 

including resource constraints, and have 

allowed for some flexibilities, such as 

back-submissions or submitting every 

business days, with the understanding 

that respondents may not have 

sufficient staff working over the 

weekend. It is our belief that collection 

of this information daily is the most 

effective way to detect outbreaks and 

needs for Federal assistance over time, 

by hospital and geographical area, and 

to alert the appropriate officials for 

action. It’s requested that 5,500 

hospitals, submit data daily on the 

number of patients tested for COVID–19, 

as well as information on bed capacity 

and requirements for other supplies. 

The HHS Teletracking COVID–19 

Portal (U.S. Healthcare COVID–19 

Portal) includes some data that were 

initially submitted by hospitals to HHS 

through CDC’s National Healthcare 

Safety Network (NHSN) COVID–19 

Module (OMB Control No. 0920–1290, 

approved 03/26/2020). Over the last 

several month’s time, the guidance for 

which data elements should be sent to 

HHS and through which method was 

updated at the request of the White 

House Coronavirus Task Force and 

other leaders to better inform the 

response. 

ESTIMATED ANNUALIZED BURDEN HOURS

Number of 

respondents 

Form name 

(electronic portal) 

Number of 

responses per 

respondents 

Total annual 

responses 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

5,500 ................. HHS Teletracking COVID–19 Portal ................................ 365 2,007,500 1.75 3,513,125 

Terry Clark, 

Office of the Secretary, Paperwork Reduction 

Act Reports Clearance Officer. 

[FR Doc. 2020–28787 Filed 12–28–20; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs (N01), 

Task Area C. 

Date: January 19, 2021. 

Time: 10:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kumud Singh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, 301–761–7830, kumud.singh@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs, Task 

Area D. 

Date: January 21, 2021. 

Time: 9:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kumud Singh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, 301–761–7830, kumud.singh@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs, Task 

Area E. 

Date: January 22, 2021. 

Time: 12:00 p.m. to 4:00 p.m. 


KHAMMOND on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 85, No. 249 / Tuesday, December 29, 2020 / Notices 85651 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kumud Singh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, 301–761–7830, kumud.singh@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Comprehensive and Rapid 

Response to NIAID Research Programs, Task 

Area F. 

Date: January 27, 2021. 

Time: 12:00 p.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G11, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Kumud Singh, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G11, Rockville, MD 

20852, 301–761–7830, kumud.singh@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 21, 2020. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–28623 Filed 12–28–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Eye Institute; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Board of Scientific 

Counselors, National Eye Institute. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended for the review, discussion, 

and evaluation of individual grant 

applications conducted by the National 

Eye Institute, including consideration of 

personnel qualifications and 

performance, and the competence of 

individual investigators, the disclosure 

of which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Board of Scientific 

Counselors, National Eye Institute. 

Date: January 26–27, 2021. 

Time: 10:30 a.m. to 5:25 p.m. 

Agenda: To review and evaluate personnel 

qualifications and performance, and 

competence of individual investigators. 

Place: National Eye Institute, National 

Institutes of Health, Building 31, Room 6A22, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: David M. Schneeweis, 

Ph.D., Acting Scientific Director, National 

Eye Institute, National Institutes of Health, 

Building 31, Room 6A22, Bethesda, MD 

20892, 301–451–6763, David.schneeweis@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.867, Vision Research, 

National Institutes of Health, HHS) 

Dated: December 22, 2020. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–28759 Filed 12–28–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; NIAID SBIR Phase II 

Clinical Trial Implementation Cooperative 

Agreement (U44); NIAID Clinical Trial 

Implementation Cooperative Agreement 

(U01); NIAID Clinical Trial Planning Grants 

(R34 Clinical Trial Not Allowed). 

Date: January 19–22, 2021. 

Time: 10:00 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3E71A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Patricia A. Gonzales 

Hurtado, Ph.D., Scientific Review Officer, 

Scientific Review Program, Division of 

Extramural Activities, National Institute of 

Allergy and Infectious Diseases, National 

Institutes of Health, 5601 Fishers Lane, Room 

3E71A, Rockville, MD 20852, 240–627–3556, 

Patricia.Gonzales@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: December 21, 2020. 

Tyeshia M. Roberson, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2020–28619 Filed 12–28–20; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Emergency Awards: Rapid 

Investigation of Severe Acute Respiratory 

Syndrome Coronavirus 2 (SARS–CoV–2) and 

Coronavirus Disease 2019 (COVID–19). 

Date: January 21–22, 2021. 

Time: 10:00 a.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G41, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Brenda Lange-Gustafson, 

Ph.D., Scientific Review Officer, Scientific 

Review Program, Division of Extramural 

Activities, National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G41, 

Rockville, MD 20852, (240) 669–5047, 

bgustafson@niaid.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 


KHAMMOND on DSKJM1Z7X2PROD with NOTICES